Stockholders’ Equity (Details) - USD ($)								1 Months Ended					3 Months Ended			9 Months Ended		12 Months Ended
		May 19, 2023	Dec. 30, 2022	Sep. 13, 2022	Jul. 11, 2022	Oct. 22, 2021	Dec. 31, 2019	Aug. 31, 2023	Aug. 30, 2023	Aug. 24, 2023	Aug. 16, 2023	Aug. 30, 2022	Sep. 30, 2023	Jun. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Feb. 16, 2021
Stockholders’ Equity (Details) [Line Items]
Common stock authorized													750,000,000			750,000,000		750,000,000
Common stock par value (in Dollars per share)													$ 0.0001			$ 0.0001		$ 0.0001
Common stock issued													13,030,034			13,030,034		12,563,426
Common stock conversion shares		72,464						144,928	2,838	173,914	72,464
Convertible debt (in Dollars)		$ 25,000						$ 50,000			$ 25,000
Interest on convertible debt (in Dollars)										$ 60,000
Expense (in Dollars)													$ 0		$ 172,766	$ 0	$ 298,298
Preferred stock, authorized													25,000,000			25,000,000		25,000,000
Preferred stock, par value (in Dollars per share)													$ 0.0001			$ 0.0001		$ 0.0001
Description of compensation service																(i) a cash endorsement fee of Three Hundred Thousand U.S. Dollars ($300,000 USD), payable as follows: (i) One Hundred Twenty-Five Thousand Dollars ($125,000) upon execution of the Endorsement Agreement, (ii) One Hundred Twenty-Five Thousand Dollars ($125,000) quarterly during the Term, beginning on the 90th day following the Effective Date, and (iii) Fifty Thousand Dollars ($50,000) on or prior to the first anniversary of the Effective Date and (ii) warrants exercisable for an aggregate of Five hundred thousand (500,000) shares of the Common Stock at an exercise price of $1.035 per share. The Warrants shall have a three-year term commencing from the Effective Date.
Shares of common stock													2,500			2,500			51,901,711
Exercise price (in Dollars per share)																$ 0.45
Expiration date												Aug. 30, 2027
Purchased shares							2,250,000
Exercise price (in Dollars per share)				$ 1.2															$ 0.24
Note amendment transaction description																the Company entered into the December 2022 Note Amendment Transaction, as fully described in note 11 above. In terms of the Note Amendment Transaction the following occurred: ●The warrants issued to Cavalry and Mercer exercisable for 165,798 shares of Common Stock (82,899 for each of Cavalry and Mercer), were exchanged for two promissory notes of $482,000 each, as disclosed in note 11 above; ●The warrants issued to Cavalry and Mercer on August 30, 2022, were subject to repricing and a full rachet increase in the number of warrants issued, resulting in an increase in the number of warrants by 2,408,696 (1,204,348 to each Cavalry and Mercer) and a reset of the exercise price to $0.345 per share. The additional warrants were valued at $841,003 using a Black-Scholes valuation model and was expensed in the statement of operations as a component of the loss on convertible debt. ●An additional 457,895 warrants previously issued to Mercer, Iroquois Master Fund and Bellridge Capital LP were subject to repricing of the exercise price from a range of $1.50 to $4.50 per share to $0.345 per share. The change in the fair value of these warrants of $20,079, using a Black-Scholes valuation model was recorded as a component of the loss on convertible debt.
Limitation exceeds percentage																9.99%
Purchase an aggregate shares																133,334
Preferred Stock, Per Share Amounts of Preferred Dividends in Arrears (in Dollars per share)																$ 0.45
Purchase shares of common stock																166,667
Additional purchase shares of common stock																166,667
Aggregate purchase of common stock																1,333,334
Warrants outstanding an intrinsic value (in Dollars)													$ 0		0	$ 0	0
Incentive stock options					500,000
Amount of immediate expense (in Dollars)																		$ 31,970
Options exercisable shares				6,667
Intrinsic value outstanding options (in Dollars)													0		0	0	0
Option expense (in Dollars)													$ 94,464		$ 950,290	$ 283,392	$ 1,139,220
Common Stock [Member]
Stockholders’ Equity (Details) [Line Items]
Common stock conversion shares	[1]												391,306	72,464
Reverse stock split	[1]												2,838
Shares of common stock												100,000
Exercise price (in Dollars per share)												$ 4.5
Exercise price (in Dollars per share)			$ 0.345
Options exercisable shares				26,668
Maximum [Member]
Stockholders’ Equity (Details) [Line Items]
Shares of common stock													26,667			26,667
Maximum [Member] | Common Stock [Member]
Stockholders’ Equity (Details) [Line Items]
Shares of common stock													100,000			100,000
Minimum [Member]
Stockholders’ Equity (Details) [Line Items]
Reverse stock split								1
Minimum [Member] | Common Stock [Member]
Stockholders’ Equity (Details) [Line Items]
Reverse stock split									1
Maximum [Member]
Stockholders’ Equity (Details) [Line Items]
Reverse stock split								30
Warrants beneficially percentage																4.99%
Maximum [Member] | Common Stock [Member]
Stockholders’ Equity (Details) [Line Items]
Reverse stock split									30
Warrant [Member]
Stockholders’ Equity (Details) [Line Items]
Purchased shares			1,000,000
Fair value of warrants (in Dollars)			$ 348,938
Purchase an aggregate shares																199,999
Chief Executive Officer [Member]
Stockholders’ Equity (Details) [Line Items]
Stock option exercise price (in Dollars per share)					$ 4.5
Amount of immediate expense (in Dollars)																		$ 823,854
Debt Conversion Notices [Member]
Stockholders’ Equity (Details) [Line Items]
Aggregate shares of common stock																4,682,093
Convertible debt amount (in Dollars)																$ 0.345
2021 Stock Incentive Plan [Member] | Maximum [Member]
Stockholders’ Equity (Details) [Line Items]
Shares of common stock						1,766,667
2018 Stock Incentive Plan [Member]
Stockholders’ Equity (Details) [Line Items]
Terminates period																10 years
2021 Stock Incentive Plan [Member]
Stockholders’ Equity (Details) [Line Items]
Terminates period						10 years

[1] After giving effect to a 1 for 30 reverse stock split on August 30, 2023.